Microglial cystatin F expression is a sensitive indicator for ongoing demyelination with concurrent remyelination

Journal of Neuroscience Research

Volumn 89, Issue 5, 2011, Pages 639-649

  Ma, Jianmei ^a,b   Tanaka, Kenji F ^b,c   Shimizu, Takahiro ^b,c   Bernard, Claude C A ^d   Kakita, Akiyoshi ^e   Takahashi, Hitoshi ^e   Pfeiffer, Steven E ^f   Ikenaka, Kazuhiro ^b,c  

^a DALIAN MEDICAL UNIVERSITY   (China)

^b NATIONAL INSTITUTE FOR PHYSIOLOGICAL SCIENCES   (Japan)

^c GRADUATE UNIVERSITY FOR ADVANCED STUDIES   (Japan)

^d MONASH UNIVERSITY   (Australia)

^e NIIGATA UNIVERSITY   (Japan)

^f UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

CNS; Cystatin F; Demyelination; Multiple sclerosis (MS); Remyelination

Indexed keywords

CYSTATIN; CYSTATIN F; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEMYELINATION; HUMAN; HUMAN TISSUE; MICROGLIA; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; REMYELINIZATION; SPINAL CORD;

ANIMALS; CELLS, CULTURED; CHRONIC DISEASE; CYSTATINS; DEMYELINATING AUTOIMMUNE DISEASES, CNS; DISEASE MODELS, ANIMAL; HUMANS; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, KNOCKOUT; MICE, NEUROLOGIC MUTANTS; MICE, TRANSGENIC; MICROGLIA; NERVE FIBERS, MYELINATED; NERVE REGENERATION; RECOVERY OF FUNCTION; TUMOR MARKERS, BIOLOGICAL;

EID: 79952519406     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22567     Document Type: Article

References (32)

1. Adkison AM, Raptis SZ, Kelley DG, Pham CT. 2002. Dipeptidyl peptidase I activates neutrophil-derived serine proteases and regulates the development of acute experimental arthritis. J Clin Invest 109: 363-371.
2. Baker CA, Manuelidis L. 2003. Unique inflammatory RNA profiles of microglia in Creutzfeldt-Jakob disease. Proc Natl Acad Sci U S A 100: 675-679.
3. Brück W, Kuhlmann T, Stadelmann C. 2003. Remyelination in multiple sclerosis. J Neurol Sci 206: 181-185.
4. Chabas D, Baranzini SE, Mitchell D, Bernard CC, Rittling SR, Denhardt DT, Sobel RA, Lock C, Karpuj M, Pedotti R, Heller R, Oksenberg JR, Steinman L. 2001. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science 294: 1731-1735.
5. Chang A, Tourtellotte WW, Rudick R, Trapp BD. 2002. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J Med 346: 165-173.
6. Chen Y, Wu H, Wang S, Koito H, Li J, Ye F, Hoang J, Escobar SS, Gow A, Arnett HA, Trapp BD, Karandikar NJ, Hsieh J, Lu QR. 2009. The oligodendrocyte-specific G protein-coupled receptor GPR17 is a cell-intrinsic timer of myelination. Nat Neurosci 12: 1398-1406.
7. Gomez CM, Muggleton-Harris AL, Whittingham DG, Hood LE, Readhead C. 1990. Rapid preimplantation detection of mutant (shiverer) and normal alleles of the mouse myelin basic protein gene allowing selective implantation and birth of live young. Proc Natl Acad Sci U S A 87: 4481-4484.
8. Halfon S, Ford J, Foster J, Dowling L, Lucian L, Sterling M, Xu Y, Weiss M, Ikeda M, Liggett D, Helms A, Caux C, Lebecque S, Hannum C, Menon S, McClanahan T, Gorman D, Zurawski G. 1998. Leukocystatin, a new class II cystatin expressed selectively by hematopoietic cells. J Biol Chem 273: 16400-16408.
9. Hamilton G, Colbert JD, Schuettelkopf AW, Watts C. 2008. Cystatin F is a cathepsin C-directed protease inhibitor regulated by proteolysis. EMBO J 27: 499-508.
10. Hanisch UK, Kettenmann H. 2007. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 10: 1387-1394.
11. Hashimoto SI, Suzuki T, Nagai S, Yamashita T, Toyoda N, Matsushima K. 2000. Identification of genes specifically expressed in human activated and mature dendritic cells through serial analysis of gene expression. Blood 96: 2206-2214.
12. John GR, Shankar SL, Shafit-Zagardo B, Massimi A, Lee SC, Raine CS, Brosnan CF. 2002. Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation. Nat Med 8: 1115-1121.
13. Kagawa T, Ikenaka K, Inoue Y, Kuriyama S, Tsujii T, Nakao J, Nakajima K, Aruga J, Okano H, Mikoshiba K. 1994. Glial cell degeneration and hypomyelination caused by overexpression of myelin proteolipid protein gene. Neuron 13: 427-442.
14. Liberski PP, Yanagihara R, Gibbs CJJr, Gajdusek DC. 1989. White matter ultrastructural pathology of experimental Creutzfeldt-Jakob disease in mice. Acta Neuropathol 79: 1-9.
15. Liberski PP, Yanagihara R, Gibbs CJJr, Gajdusek DC. 1991. Mechanism of the damage to myelinated axons in experimental Creutzfeldt-Jakob disease in mice: an ultrastructural study. Eur J Epidemiol 7: 545-550.
16. Ma J, Matsumoto M, Tanaka KF, Takebayashi H, Ikenaka K. 2006. An animal model for late onset chronic demyelination disease caused by failed terminal differentiation of oligodendrocytes. Neuron Glia Biol 2: 81-91.
17. Ma J, Tanaka KF, Yamada G, Ikenaka K. 2007. Induced expression of cathepsins and cystatin C in a murine model of demyelination. Neurochem Res 32: 311-320.
18. March M, Biddle F, Miller JR. 1973. Research news: an apparently new mutation. Mouse Newslett 48: 24.
19. Mason JL, Langaman C, Morell P, Suzuki K, Matsushima GK. 2001. Episodic demyelination and subsequent remyelination within the murine central nervous system: changes in axonal calibre. Neuropathol Appl Neurobiol 27: 50-58.
20. Mason JL, Toews A, Hostettler JD, Morell P, Suzuki K, Goldman JE, Matsushima GK. 2004. Oligodendrocytes and progenitors become progressively depleted within chronically demyelinated lesions. Am J Pathol 164: 1673-1682.
21. Menon K, Rasband MN, Taylor CM, Brophy P, Bansal R, Pfeiffer SE. 2003. The myelin-axolemmal complex: biochemical dissection and the role of galactosphingolipids. J Neurochem 87: 995-1009.
22. Morita M, Yoshiuchi N, Arakawa H, Nishimura S. 1999. CMAP: a novel cystatin-like gene involved in liver metastasis. Cancer Res 59: 151-158.
23. Nakagawa T, Roth W, Wong P, Nelson A, Farr A, Deussing J, Villadangos JA, Ploegh H, Peters C, Rudensky AY. 1998. Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus. Science 280: 450-453.
24. Ni J, Fernandez MA, Danielsson L, Chillakuru RA, Zhang J, Grubb A, Su J, Gentz R, Abrahamson M. 1998. Cystatin F is a glycosylated human low molecular weight cysteine proteinase inhibitor. J Biol Chem 273: 24797-24804.
25. + T lymphocytes. Int Immunol 14: 1085-1098.
26. Okuda Y, Okuda M, Bernard CC. 2002. Gender does not influence the susceptibility of C57BL/6 mice to develop chronic experimental autoimmune encephalomyelitis induced by myelin oligodendrocyte glycoprotein. Immunol Lett 81: 25-29.
27. Phillips RJ. 1954. Jimpy, a new totally sexlinked gene in the house mouse. Z Indukt Abstamm Vererbungsl 86: 322-326.
28. Raivich G, Gehrmann J, Kreutzberg GW. 1991. Increase of macrophage colony-stimulating factor and granulocyte-macrophage colony-stimulating factor receptors in the regenerating rat facial nucleus. J Neurosci Res 30: 682-686.
29. Sawada M, Suzumura A, Yamamoto H, Marunouchi T. 1990. Activation and proliferation of the isolated microglia by colony stimulating factor-1 and possible involvement of protein kinase C. Brain Res 509: 119-124.
30. Tanaka KF, Kashima H, Suzuki H, Ono K, Sawada M. 2002. Existence of functional beta1- and beta2-adrenergic receptors on microglia. J Neurosci Res 70: 232-237.
31. Toda T, Hayakawa I, Matsubayashi Y, Tanaka K, Ikenaka K, Lu QR, Kawasaki H. 2008. Termination of lesion-induced plasticity in the mouse barrel cortex in the absence of oligodendrocytes. Mol Cell Neurosci 39: 40-49.
32. Yamamura T, Konola JT, Wekerle H, Lees MB. 1991. Monoclonal antibodies against myelin proteolipid protein: identification and characterization of two major determinants. J Neurochem 57: 1671-1680.